Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Bauer

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Stroke|May 28, 2013
Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversalKenneth A Bauer
American Journal of Orthopedics (Belle Mead, N.J.)|December 5, 2002
Fondaparinux: basic properties and efficacy and safety in venous thromboembolism prophylaxisKenneth A Bauer
American Journal of Hematology|March 31, 2012
Reversal of antithrombotic agentsKenneth A Bauer
Clinical Advances in Hematology & Oncology : H&O|May 28, 2010
Thrombophilia evaluation: the value of testing relativesKenneth A Bauer
JAMA|March 10, 2011
Long-term management of venous thromboembolism: a 61-year-old woman with unprovoked venous thromboembolismKenneth A Bauer
The American Journal of Managed Care|July 14, 2015
Current challenges in the management of hemophiliaKenneth A Bauer
Journal of Thrombosis and Thrombolysis|February 14, 2006
New anticoagulants: anti IIa vs anti Xa--is one better?Kenneth A Bauer
Current Opinion in Hematology|August 13, 2008
New anticoagulantsKenneth A Bauer
JAMA|January 15, 2020
How Effective and Safe Is Factor XI Inhibition in Preventing Venous Thrombosis?Kenneth A Bauer
Chest|December 12, 2003
New pentasaccharides for prophylaxis of deep vein thrombosis: pharmacologyKenneth A Bauer
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Stroke|May 28, 2013
Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversalKenneth A Bauer
American Journal of Orthopedics (Belle Mead, N.J.)|December 5, 2002
Fondaparinux: basic properties and efficacy and safety in venous thromboembolism prophylaxisKenneth A Bauer
American Journal of Hematology|March 31, 2012
Reversal of antithrombotic agentsKenneth A Bauer
Clinical Advances in Hematology & Oncology : H&O|May 28, 2010
Thrombophilia evaluation: the value of testing relativesKenneth A Bauer
JAMA|March 10, 2011
Long-term management of venous thromboembolism: a 61-year-old woman with unprovoked venous thromboembolismKenneth A Bauer
The American Journal of Managed Care|July 14, 2015
Current challenges in the management of hemophiliaKenneth A Bauer
Journal of Thrombosis and Thrombolysis|February 14, 2006
New anticoagulants: anti IIa vs anti Xa--is one better?Kenneth A Bauer
Current Opinion in Hematology|August 13, 2008
New anticoagulantsKenneth A Bauer
JAMA|January 15, 2020
How Effective and Safe Is Factor XI Inhibition in Preventing Venous Thrombosis?Kenneth A Bauer
Chest|December 12, 2003
New pentasaccharides for prophylaxis of deep vein thrombosis: pharmacologyKenneth A Bauer
Pageof 10